Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease

Frontiers in Molecular Neuroscience

Volumn 6, Issue NOV, 2013, Pages

  Czeredys, Magdalena ^a   Gruszczynska Biegala, Joanna ^a   Schacht, Teresa ^b   Methner, Axel ^b   Kuznicki, Jacek ^a,c  

^a INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Calcium signalosome; Calcyclin binding protein; Huntingtin; Huntingtin associated protein 1; Huntington's disease; Store operated calcium entry; Taqman low density arrays; Transgenic mice

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CALRETININ; HUNTINGTIN; PRESENILIN 2; SEPTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CONTROLLED STUDY; DENSITOMETRY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE MUTATION; HUNTINGTON CHOREA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

EID: 84888331632     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2013.00042     Document Type: Article

References (84)

1. Apostol, B. L., Kazantsev, A., Raffioni, S., Illes, K., Pallos, J., Bodai, L., et al. (2003). A cell-based assay for aggregation inhibitors as therapeutics of polyglutaminerepeat disease and validation in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 100, 5950-5955. doi: 10.1073/pnas.2628045100
2. Bao, J., Sharp, A. H., Wagster, M. V., Becher, M., Schilling, G., Ross, C. A., et al. (1996). Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc. Natl. Acad. Sci. U.S.A. 93, 5037-5042. doi: 10.1073/pnas.93.10.5037
3. Berman, D. M., Kozasa, T., and Gilman, A. G. (1996). The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J. Biol. Chem. 271, 27209-27212. doi: 10.1074/jbc.271.44.27209
4. Bernstein, H. G., Blazejczyk, M., Rudka, T., Gundelfinger, E. D., Dobrowolny, H., Bogerts, B., et al. (2005). The Alzheimer disease-related calcium-binding protein Calmyrin is present in human forebrain with an altered distribution in Alzheimer's as compared to normal ageing brains. Neuropathol. Appl. Neurobiol. 31, 314-324. doi: 10.1111/j.1365-2990.2005.00646.x
5. Berridge, M. J. (2012). Calcium signalling remodelling and disease. Biochem. Soc. Trans. 40, 297-309. doi: 10.1042/BST20110766
6. Berridge, M. J., Bootman, M. D., and Roderick, H. L. (2003). Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517-529. doi: 10.1038/nrm1155
7. Bezprozvanny, I., and Hayden, M. R. (2004). Deranged neuronal calcium signaling and Huntington disease. Biochem. Biophys. Res. Commun. 322, 1310-1317. doi: 10.1016/j.bbrc.2004.08.035
8. Bezprozvanny, I. B. (2010). Calcium signaling and neurodegeneration. Acta Nat. 2, 72-82.
9. Billing-Marczak, K., and Kuznicki, J. (1999). Calretinin-sensor or buffer-function still unclear. Pol. J. Pharmacol. 51, 173-178.
10. Blazejczyk, M., Sobczak, A., Debowska, K., Wisniewska, M. B., Kirilenko, A., Pikula, S., et al. (2009). Biochemical characterization and expression analysis of a novel EF-hand Ca2+ binding protein calmyrin2 (Cib2) in brain indicates its function in NMDA receptor mediated Ca2+ signaling. Arch. Biochem. Biophys. 487, 66-78. doi: 10.1016/j.abb.2009.05.002
11. Blazejczyk, M., Wojda, U., Sobczak, A., Spilker, C., Bernstein, H. G., Gundelfinger, E. D., et al. (2006). Ca2+-independent binding and cellular expression profiles question a significant role of calmyrin in transduction of Ca2+-signals to Alzheimer's disease-related presenilin 2 in forebrain. Biochim. Biophys. Acta 1762, 66-72. doi: 10.1016/j.bbadis.2005.09.006
12. Chin, D., and Means, A. R. (2000). Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 10, 322-328. doi: 10.1016/S0962-8924(00)01800-6
13. Cicchetti, F., and Parent, A. (1996). Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons. Mov. Disord. 11, 619-626. doi: 10.1002/mds.870110605
14. Cong, S. Y., Pepers, B. A., Evert, B. O., Rubinsztein, D. C., Roos, R. A., van Ommen, G. J., et al. (2005). Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol. Cell. Neurosci. 30, 560-571. doi: 10.1016/j.mcn.2005.05.003
15. Desplats, P. A., Kass, K. E., Gilmartin, T., Stanwood, G. D., Woodward, E. L., Head, S. R., et al. (2006). Selective deficits in the expression of striatalenriched mRNAs in Huntington's disease. J. Neurochem. 96, 743-757. doi: 10.1111/j.1471-4159.2005.03588.x
16. Dong, G., Gross, K., Qiao, F., Ferguson, J., Callegari, E. A., Rezvani, K., et al. (2012). Calretinin interacts with huntingtin and reduces mutant huntingtincaused cytotoxicity. J. Neurochem. 123, 437-446. doi: 10.1111/j.14714159.2012.07919.x
17. Filipek, A., Jastrzebska, B., Nowotny, M., and Kuznicki, J. (2002). CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J. Biol. Chem. 277, 28848-28852. doi: 10.1074/jbc.M203602200
18. Filipek, A., and Kuznicki, J. (1998). Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J. Neurochem. 70, 1793-1798. doi: 10.1046/j.1471-4159.1998.70051793.x
19. Filipek, A., Schneider, G., Mietelska, A., Figiel, I., and Niewiadomska, G. (2008). Age-dependent changes in neuronal distribution of CacyBP/SIP: comparison to tubulin and the tau protein. J. Neural Transm. 115, 1257-1264. doi: 10.1007/s00702-008-0062-3
20. Foskett, J. K., White, C., Cheung, K. H., and Mak, D. O. (2007). Inositol trisphosphate receptor Ca2+ release channels. Physiol. Rev. 87, 593-658. doi: 10.1152/physrev.00035.2006
21. Francis, R., McGrath, G., Zhang, J., Ruddy, D. A., Sym, M., Apfeld, J., et al. (2002). aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell 3, 85-97. doi: 10.1016/S1534-5807(02)00189-2
22. Frischauf, I., Schindl, R., Derler, I., Bergsmann, J., Fahrner, M., and Romanin, C. (2008). The STIM/Orai coupling machinery. Channels (Austin) 2, 261-268. doi: 10.4161/chan.2.4.6705
23. Giacomello, M., Hudec, R., and Lopreiato, R. (2011). Huntington's disease, calcium, and mitochondria. Biofactors 37, 206-218. doi: 10.1002/biof.162
24. Giacomello, M., Oliveros, J. C., Naranjo, J. R., and Carafoli, E. (2013). Neuronal Ca(2+) dyshomeostasis in Huntington disease. Prion 7, 76-84. doi: 10.4161/pri.23581
25. Goutte, C., Tsunozaki, M., Hale, V. A., and Priess, J. R. (2002). APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc. Natl. Acad. Sci. U.S.A. 99, 775-779. doi: 10.1073/pnas.022523499
26. Groenendyk, J., Lynch, J., and Michalak, M. (2004). Calreticulin, Ca2+, and calcineurin signaling from the endoplasmic reticulum. Mol. Cells 17, 383-389.
27. Gruszczynska-Biegala, J., and Kuznicki, J. (2013). Native STIM2 and ORAI1 proteins form a calcium-sensitive and thapsigargin-insensitive complex in cortical neurons. J. Neurochem. 126, 727-738. doi: 10.1111/jnc.12320
28. Gruszczynska-Biegala, J., Pomorski, P., Wisniewska, M. B., and Kuznicki, J. (2011). Differential roles for STIM1 and STIM2 in store-operated calcium entry in rat neurons. PLoS ONE 6:e19285. doi: 10.1371/journal.pone.0019285
29. Hamilton, S. L. (2005). Ryanodine receptors. Cell Calcium 38, 253-260. doi: 10.1016/j.ceca.2005.06.037
30. Henke, N., Albrecht, P., Bouchachia, I., Ryazantseva, M., Knoll, K., Lewerenz, J., et al. (2013). The plasma membrane channel ORAI1 mediates detrimental calcium influx caused by endogenous oxidative stress. Cell Death Dis. 4:e470. doi: 10.1038/cddis.2012.216
31. Henke, N., Albrecht, P., Pfeiffer, A., Toutzaris, D., Zanger, K., and Methner, A. (2012). Stromal interaction molecule 1 (STIM1) is involved in the regulation of mitochondrial shape and bioenergetics and plays a role in oxidative stress. J. Biol. Chem. 287, 42042-42052. doi: 10.1074/jbc.M112.417212
32. Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A., Sengstag, T., Hughes, G., et al. (2006). Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet. 15, 965-977. doi: 10.1093/hmg/ddl013
33. Huang, C., Hepler, J. R., Gilman, A. G., and Mumby, S. M. (1997). Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 94, 6159-6163. doi: 10.1073/pnas.94.12.6159
34. Huang, G. N., Zeng, W., Kim, J. Y., Yuan, J. P., Han, L., Muallem, S., et al. (2006). STIM1 carboxyl-terminus activates native SOC, I(crac) and TRPC1 channels. Nat. Cell Biol. 8, 1003-1010. doi: 10.1038/ncb1454
35. Jaworska, A., Dzbek, J., Styczynska, M., and Kuznicki, J. (2013). Analysis of calcium homeostasis in fresh lymphocytes from patients with sporadic Alzheimer's disease or mild cognitive impairment. Biochim. Biophys. Acta 1833, 1692-1699. doi: 10.1016/j.bbamcr.2013.01.012
36. Jurewicz, E., Ostrowska, Z., Jozwiak, J., Redowicz, M. J., Lesniak, W., Moraczewska, J., et al. (2013). CacyBP/SIP as a novel modulator of the thin filament. Biochim. Biophys. Acta 1833, 761-766. doi: 10.1016/j.bbamcr.2012.12.010
37. Klejman, M. E., Gruszczynska-Biegala, J., Skibinska-Kijek, A., Wisniewska, M. B., Misztal, K., Blazejczyk, M., et al. (2009). Expression of STIM1 in brain and puncta-like co-localization of STIM1 and ORAI1 upon depletion of Ca(2+) store in neurons. Neurochem. Int. 54, 49-55. doi: 10.1016/j.neuint.2008.10.005
38. Lee, S. F., Shah, S., Yu, C., Wigley, W. C., Li, H., Lim, M., et al. (2004). A conserved GXXXG motif in APH-1 is critical for assembly and activity of the gammasecretase complex. J. Biol. Chem. 279, 4144-4152. doi: 10.1074/jbc.M309745200
39. Leissring, M. A., Akbari, Y., Fanger, C. M., Cahalan, M. D., Mattson, M. P., and LaFerla, F. M. (2000). Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149, 793-798. doi: 10.1083/jcb.149.4.793
40. Li, S. H., Hosseini, S. H., Gutekunst, C. A., Hersch, S. M., Ferrante, R. J., and Li, X. J. (1998). A human HAP1 homologue. Cloning, expression, and interaction with huntingtin. J. Biol. Chem. 273, 19220-19227. doi: 10.1074/jbc.273.30.19220
41. Li, S. H., and Li, X. J. (2004). Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet. 20, 146-154. doi: 10.1016/j.tig.2004.01.008
42. Li, X. J., Li, S. H., Sharp, A. H., Nucifora, F. C. Jr., Schilling, G., et al. (1995). A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398-402. doi: 10.1038/378398a0
43. Liou, J., Kim, M. L., Heo, W. D., Jones, J. T., Myers, J. W., Ferrell, J. E., et al. (2005). STIM is a Ca2+ sensor essential for Ca2+-store-depletiontriggered Ca2+ influx. Curr. Biol. 15, 1235-1241. doi: 10.1016/j.cub.2005.05.055
44. Luo, W. J., Wang, H., Li, H., Kim, B. S., Shah, S., Lee, H. J., et al. (2003). PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. J. Biol. Chem. 278, 7850-7854. doi: 10.1074/jbc.C200648200
45. Luthi-Carter, R., Hanson, S. A., Strand, A. D., Bergstrom, D. A., Chun, W., Peters, N. L., et al. (2002a). Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet. 11, 1911-1926. doi: 10.1093/hmg/11.17.1911
46. Luthi-Carter, R., Strand, A. D., Hanson, S. A., Kooperberg, C., Schilling, G., La Spada, A. R., et al. (2002b). Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum. Mol. Genet. 11, 1927-1937. doi: 10.1093/hmg/11.17.1927
47. Luthi-Carter, R., Strand, A., Peters, N. L., Solano, S. M., Hollingsworth, Z. R., Menon, A. S., et al. (2000). Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9, 1259-1271. doi: 10.1093/hmg/9.9.1259
48. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., et al. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506. doi: 10.1016/S0092-8674(00)81369-0
49. Massouh, M., Wallman, M. J., Pourcher, E., and Parent, A. (2008). The fate of the large striatal interneurons expressing calretinin in Huntington's disease. Neurosci. Res. 62, 216-224. doi: 10.1016/j.neures.2008.08.007
50. Matsuzawa, S. I., and Reed, J. C. (2001). Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell 7, 915-926. doi: 10.1016/S1097-2765(01)00242-8
51. Michalak, M., Groenendyk, J., Szabo, E., Gold, L. I., and Opas, M. (2009). Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem. J. 417, 651-666. doi: 10.1042/BJ20081847
52. Moores, J. N., Roy, S., Nicholson, D. W., and Staveley, B. E. (2008). Huntingtin interacting protein 1 can regulate neurogenesis in Drosophila. Eur. J. Neurosci. 28, 599-609. doi: 10.1111/j.1460-9568.2008.06359.x
53. Ng, A. N., Krogh, M., and Toresson, H. (2011). Dendritic EGFP-STIM1 activation after type I metabotropic glutamate and muscarinic acetylcholine receptor stimulation in hippocampal neuron. J. Neurosci. Res. 89, 1235-1244. doi: 10.1002/jnr.22648
54. Nikoletopoulou, V., and Tavernarakis, N. (2012). Calcium homeostasis in aging neurons. Front. Genet. 3:200. doi: 10.3389/fgene.2012.00200
55. Noble, W. S. (2009). How does multiple testing correction work? Nat. Biotechnol. 27, 1135-1137. doi: 10.1038/nbt1209-1135
56. Park, C. Y., Shcheglovitov, A., and Dolmetsch, R. (2010). The CRAC channel activator STIM1 binds and inhibits L-type voltage-gated calcium channels. Science 330, 101-105. doi: 10.1126/science.1191027
57. Paxinos, G., and Franklin, K. B. J. (2004). The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
58. Puzianowska-Kuznicka, M., and Kuznicki, J. (2009). The ER and ageing II: calcium homeostasis. Ageing Res. Rev. 8, 160-172. doi: 10.1016/j.arr.2009.05.002
59. Ribeiro, F. M., Paquet, M., Ferreira, L. T., Cregan, T., Swan, P., Cregan, S. P., et al. (2010). Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease. J. Neurosci. 30, 316-324. doi: 10.1523/JNEUROSCI.4974-09.2010
60. Rockabrand, E., Slepko, N., Pantalone, A., Nukala, V. N., Kazantsev, A., Marsh, J. L., et al. (2007). The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum. Mol. Genet. 16, 61-77. doi: 10.1093/hmg/ ddl440
61. Roos, J., DiGregorio, P. J., Yeromin, A. V., Ohlsen, K., Lioudyno, M., Zhang, S., et al. (2005). STIM1, an essential and conserved component of store-operated Ca2+ channel function. J. Cell Biol. 169, 435-445. doi: 10.1083/jcb.2005 02019
62. Ryazantseva, M., Skobeleva, K., and Kaznacheyeva, E. (2013). Familial Alzheimer's disease-linked presenilin-1 mutation M146V affects store-operated calcium entry: does gain look like loss? Biochimie 95, 1506-1509. doi: 10.1016/j.biochi.2013.04.009
63. Seto-Ohshima, A., Emson, P. C., Lawson, E., Mountjoy, C. Q., and Carrasco, L. H. (1988). Loss of matrix calcium-binding protein-containing neurons in Huntington's disease. Lancet 1, 1252-1255. doi: 10.1016/S0140-6736(88) 92073-9
64. Sharma, S., Quintana, A., Findlay, G. M., Mettlen, M., Baust, B., Jain, M., et al. (2013). An siRNA screen for NFAT activation identifies septins as coordinators of store-operated Ca2+ entry. Nature 499, 238-242. doi: 10.1038/nature12229
65. Skibinska-Kijek, A., Wisniewska, M. B., Gruszczynska-Biegala, J., Methner, A., and Kuznicki, J. (2009). Immunolocalization of STIM1 in the mouse brain. Acta Neurobiol. Exp. (Wars) 69, 413-428.
66. Slow, E. J., van Raamsdonk, J., Rogers, D., Coleman, S. H., Graham, R. K., Deng, Y., et al. (2003). Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12, 1555-1567. doi: 10.1093/hmg/ddg169
67. Steinbeck, J. A., Henke, N., Opatz, J., Gruszczynska-Biegala, J., Schneider, L., Theiss, S., et al. (2011). Store-operated calcium entry modulates neuronal network activity in a model of chronic epilepsy. Exp. Neurol. 232, 185-194. doi: 10.1016/j.expneurol.2011.08.022
68. Sugars, K. L., and Rubinsztein, D. C. (2003). Transcriptional abnormalities in Huntington disease. Trends Genet. 19, 233-238. doi: 10.1016/S0168-9525(03)00074-X
69. Supnet, C., and Bezprozvanny, I. (2011). Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis. Cell Calcium 50, 303-309. doi: 10.1016/j.ceca.2011.05.013
70. Tang, T. S., Slow, E., Lupu, V., Stavrovskaya, I. G., Sugimori, M., Llinas, R., et al. (2005). Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 102, 2602-2607. doi: 10.1073/pnas.0409402102
71. Tang, T. S., Tu, H., Chan, E. Y., Maximov, A., Wang, Z., Wellington, C. L., et al. (2003). Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 39, 227-239. doi: 10.1016/S0896-6273(03)00366-0
72. Tang, T. S., Tu, H., Orban, P. C., Chan, E. Y., Hayden, M. R., and Bezprozvanny, I. (2004). HAP1 facilitates effects of mutant huntingtin on inositol 1,4,5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons. Eur. J. Neurosci. 20, 1779-1787. doi: 10.1111/j.1460-9568.2004. 03633.x
73. Tarlac, V., and Storey, E. (2003). Role of proteolysis in polyglutamine disorders. J. Neurosci. Res. 74, 406-416. doi: 10.1002/jnr.10746
74. Toescu, E. C., and Verkhratsky, A. (2007). The importance of being subtle: small changes in calcium homeostasis control cognitive decline in normal aging. Aging Cell 6, 267-273. doi: 10.1111/j.1474-9726.2007.00296.x
75. Van Raamsdonk, J. M., Warby, S. C., and Hayden, M. R. (2007). Selective degeneration in YAC mouse models of Huntington disease. Brain Res. Bull. 72, 124-131. doi: 10.1016/j.brainresbull.2006.10.018
76. van Roon-Mom, W. M., Pepers, B. A., t Hoen, P. A., Verwijmeren, C. A., den Dunnen, J. T., Dorsman, J. C., et al. (2008). Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease. BMC Mol. Biol. 9:84. doi: 10.1186/1471-2199-9-84
77. Vig, M., Peinelt, C., Beck, A., Koomoa, D. L., Rabah, D., Koblan-Huberson, M., et al. (2006). CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 312, 1220-1223. doi: 10.1126/science.1127883
78. Vonsattel, J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D., and Richardson, E. P. Jr. (1985). Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577. doi: 10.1097/00005072198511000-00003
79. Winsky, L., and Kuznicki, J. (1996). Antibody recognition of calcium-binding proteins depends on their calcium-binding status. J. Neurochem. 66, 764-771. doi: 10.1046/j.1471-4159.1996.66020764.x
80. Wojda, U., Salinska, E., and Kuznicki, J. (2008). Calcium ions in neuronal degeneration. IUBMB Life 60, 575-590. doi: 10.1002/iub.91
81. Wu, J., Shih, H. P., Vigont, V., Hrdlicka, L., Diggins, L., Singh, C., et al. (2011). Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment. Chem. Biol. 18, 777-793. doi: 10.1016/j.chembiol.2011.04.012
82. Wu, L. L., and Zhou, X. F. (2009). Huntingtin associated protein 1 and its functions. Cell Adh. Migr. 3, 71-76. doi: 10.4161/cam.3.1.7511
83. Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., et al. (2002). Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33, 849-860. doi: 10.1016/S0896-6273(02)00615-3
84. Zucker, B., Luthi-Carter, R., Kama, J. A., Dunah, A. W., Stern, E. A., Fox, J. H., et al. (2005). Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1. Hum. Mol. Genet. 14, 179-189. doi: 10.1093/hmg/ddi014